---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-034212"
form_type: "8-K/A"
ticker: "FOXO"
cik: "0001812360"
company_name: "FOXO TECHNOLOGIES INC."
filed_at: "2024-08-28T23:59:59+00:00"
generated_at: "2026-05-31T07:14:01.204317+00:00"
event_type: "m_and_a"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# FOXO files financials for Myrtle Recovery acquisition; Myrtle had $1.1M net loss in 2023

## Summary
- Acquired 98.4% of Myrtle for $500k consideration: 1,023,629 FOXO shares ($0.23/share) plus $264,565 demand note.
- Myrtle's audited FY2023: net loss $1,086,357, revenue $139,550, negative equity $1,118,553.
- Myrtle's auditor notes substantial doubt as going concern due to recurring losses and working capital deficit of $1.4M.
- Myrtle operates two Tennessee-licensed behavioral health facilities; started accepting patients in Aug 2023.
- Pro forma financials filed for FOXO for six months ended June 30, 2024 and year ended Dec 31, 2023.

## SEC filing metadata
- accession: 0001493152-24-034212
- form_type: 8-K/A
- ticker: FOXO
- cik: 0001812360
- company_name: FOXO TECHNOLOGIES INC.
- filed_at: 2024-08-28T23:59:59+00:00
- event_type: m_and_a
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1812360/000149315224034212/0001493152-24-034212-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1812360/000149315224034212/form8-ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-034212
- JSON: https://secwatch.observer/filing/0001493152-24-034212.json
- Plain text: https://secwatch.observer/filing/0001493152-24-034212.txt

## Key facts
- M&A Transactions
  FOXO TECHNOLOGIES INC. completed an acquisition involving Rennova Health, Inc. for $500,000 (closed 2024-07-17).
  - Action: acquisition
  - Counterparty: Rennova Health, Inc.
  - Consideration: $500,000
  - Closing: 2024-07-17
  source text: exchanged with the Company 100 shares of Common Stock of Myrtle (which represents 98.4% of the issued and outstanding shares of Myrtle Common Stock) for total consideration of $500,000 (the “ Myrtle Purchase Price ”), which payment was made by the issuance of a number of shares of Class A Common Stock of the Company determined by dividing $500,000 by the volume
  evidence_url: https://www.sec.gov/Archives/edgar/data/1812360/000149315224034212/0001493152-24-034212-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.